Email this article to a friend
Adalimumab clinical efficacy is associated with rheumatoid factor and anti-cyclic citrullinated peptide antibody titer reduction: a one-year prospective study
-
* Corresponding author: Piercarlo Sarzi-Puttini sarzi@tiscali.it
Arthritis Research & Therapy 2006, 8:R3 doi:10.1186/ar1851